These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 34861684)

  • 1. Can Intralesional Epidermal Growth Factor Reduce Skin Graft Applications in Patients with Diabetic Foot Ulcer?
    Colak B; Yormaz S; Ece I; Sahin M
    J Am Podiatr Med Assoc; 2021 Sep; 111(5):. PubMed ID: 34861684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralesional epidermal growth factor therapy in recalcitrant diabetic foot ulcers.
    Özker E
    J Wound Care; 2023 Apr; 32(Sup4):S14-S21. PubMed ID: 37029977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: a randomized double-blinded controlled trial.
    Gomez-Villa R; Aguilar-Rebolledo F; Lozano-Platonoff A; Teran-Soto JM; Fabian-Victoriano MR; Kresch-Tronik NS; Garrido-Espíndola X; Garcia-Solis A; Bondani-Guasti A; Bierzwinsky-Sneider G; Contreras-Ruiz J
    Wound Repair Regen; 2014; 22(4):497-503. PubMed ID: 25041620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Assessment of Intralesional Epidermal Growth Factor for Treating Diabetic Foot Wounds
    Ertugrul BM; Lipsky BA; Guvenc U;
    J Am Podiatr Med Assoc; 2017 Jan; 107(1):17-29. PubMed ID: 28271944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralesional application of epidermal growth factor in limb-threatening ischemic diabetic foot ulcers.
    Aktaş Ş; Baktıroğlu S; Demir L; Kılıçoğlu Ö; Topalan M; Güven E; Mirasoğlu B; Yanar F
    Acta Orthop Traumatol Turc; 2016; 50(3):277-83. PubMed ID: 27130382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of injectable acellular dermal matrix combined with negative pressure wound therapy in open diabetic foot amputation.
    Ahn J; Park HY; Shetty AA; Hwang W
    J Wound Care; 2022 Apr; 31(4):310-320. PubMed ID: 35404696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of leukocyte-platelet fibrin-rich wound reconstruction followed by full-thickness skin grafting in the treatment of diabetic foot Wagner grade 4 ulcer gangrene (toe area).
    Wang Y; Wang Y; Wang X; Zhao Y; Ruan S; Cao H
    Platelets; 2023 Dec; 34(1):2131752. PubMed ID: 36210791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of intralesional recombinant human epidermal growth factor in chronic diabetic foot ulcers.
    Dumantepe M; Fazliogullari O; Seren M; Uyar I; Basar F
    Growth Factors; 2015 Apr; 33(2):128-32. PubMed ID: 25856197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional Epidermal Growth Factor for Diabetic Foot Ulcers.
    Ilkeli E; Goktas Demircan FB; Duzgun AC; Arabaci H; Uysal A; Kanko M
    J Coll Physicians Surg Pak; 2022 Mar; 32(3):278-282. PubMed ID: 35148575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Long-Term Outcomes Following the Application of Intralesional Epidermal Growth Factor in Patients With Diabetic Foot Ulcers.
    Kahraman M; Misir A; Kizkapan TB; Ozcamdalli M; Uzun E; Mutlu M
    J Foot Ankle Surg; 2019 Mar; 58(2):282-287. PubMed ID: 30612874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor effect on lipopolysaccharide-induced inflammation in fibroblasts derived from diabetic foot ulcer.
    Mendoza-Marí Y; García-Ojalvo A; Fernández-Mayola M; Rodríguez-Rodríguez N; Martinez-Jimenez I; Berlanga-Acosta J
    Scars Burn Heal; 2022; 8():20595131211067380. PubMed ID: 35198238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers.
    Yera-Alos IB; Alonso-Carbonell L; Valenzuela-Silva CM; Tuero-Iglesias AD; Moreira-Martínez M; Marrero-Rodríguez I; López-Mola E; López-Saura PA
    BMC Pharmacol Toxicol; 2013 Sep; 14():44. PubMed ID: 24004460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation.
    Fernández-Montequín JI; Infante-Cristiá E; Valenzuela-Silva C; Franco-Pérez N; Savigne-Gutierrez W; Artaza-Sanz H; Morejón-Vega L; González-Benavides C; Eliseo-Musenden O; García-Iglesias E; Berlanga-Acosta J; Silva-Rodríguez R; Betancourt BY; López-Saura PA;
    Int Wound J; 2007 Dec; 4(4):333-43. PubMed ID: 17953679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proximal Tibial Cortex Transverse Distraction Facilitating Healing and Limb Salvage in Severe and Recalcitrant Diabetic Foot Ulcers.
    Chen Y; Kuang X; Zhou J; Zhen P; Zeng Z; Lin Z; Gao W; He L; Ding Y; Liu G; Qiu S; Qin A; Lu W; Lao S; Zhao J; Hua Q
    Clin Orthop Relat Res; 2020 Apr; 478(4):836-851. PubMed ID: 31794478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the Effect of the Five-in-One Comprehensive Limb Salvage Technologies of Treating Severe Diabetic Foot.
    Liu Y; Shi Y; Zhu J; Chen X; Yang R; Shu B; Zhou Z; Liu J; Wu RQ; Xie J
    Adv Wound Care (New Rochelle); 2020 Dec; 9(12):676-685. PubMed ID: 33124965
    [No Abstract]   [Full Text] [Related]  

  • 16. Changing the patterns of hospitalized diabetic foot ulcer (DFU) over a 5-year period in a multi-disciplinary setting in Thailand.
    Thewjitcharoen Y; Sripatpong J; Krittiyawong S; Porramatikul S; Srikummoon T; Mahaudomporn S; Butadej S; Nakasatien S; Himathongkam T
    BMC Endocr Disord; 2020 Jun; 20(1):89. PubMed ID: 32571283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of healing, ulcer recurrence and persistence, amputation and mortality in type 2 diabetic patients with diabetic foot: a 10-year retrospective cohort study.
    Gazzaruso C; Gallotti P; Pujia A; Montalcini T; Giustina A; Coppola A
    Endocrine; 2021 Jan; 71(1):59-68. PubMed ID: 32712853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of lower extremity amputation in patients with diabetic foot ulcer: findings from MEDFUN, a multi-center observational study.
    Ugwu E; Adeleye O; Gezawa I; Okpe I; Enamino M; Ezeani I
    J Foot Ankle Res; 2019; 12():34. PubMed ID: 31223342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic foot wounds.
    Acosta JB; Savigne W; Valdez C; Franco N; Alba JS; del Rio A; López-Saura P; Guillén G; Lopez E; Herrera L; Férnandez-Montequín J
    Int Wound J; 2006 Sep; 3(3):232-9. PubMed ID: 16984579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Diabetic Foot Ulcers in a Tertiary Referral Interdisciplinary Clinic: A Retrospective Canadian Study.
    Fournier C; Singbo N; Morissette N; Thibeault MM
    Can J Diabetes; 2021 Apr; 45(3):255-260. PubMed ID: 33160884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.